BRAF Targets in Melanoma

Biological Mechanisms, Resistance, and Drug Discovery

Nonfiction, Science & Nature, Science, Other Sciences, Molecular Biology, Health & Well Being, Medical, Specialties, Oncology
Cover of the book BRAF Targets in Melanoma by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781493921430
Publisher: Springer New York Publication: November 24, 2014
Imprint: Humana Language: English
Author:
ISBN: 9781493921430
Publisher: Springer New York
Publication: November 24, 2014
Imprint: Humana
Language: English

​This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

​This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.

More books from Springer New York

Cover of the book Handbook of Water and Wastewater Systems Protection by
Cover of the book Transporters in Drug Development by
Cover of the book The Europeanization of Domestic Legislatures by
Cover of the book Observational Studies by
Cover of the book Ramanujan's Lost Notebook by
Cover of the book Error Control for Network-on-Chip Links by
Cover of the book Twitter Data Analytics by
Cover of the book Immunocomputing by
Cover of the book Nanotechnology in Drug Delivery by
Cover of the book PBX Security and Forensics by
Cover of the book An Indispensable Truth by
Cover of the book Biomimetics in Materials Science by
Cover of the book Developing Biofuel Bioprocesses Using Systems and Synthetic Biology by
Cover of the book Beta maritima by
Cover of the book The Multiple Ligament Injured Knee by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy